Tag: Cancer: Lymphoma
Childhood Hodgkin Lymphoma Survivors at Risk for Later Cancers
Survivors have 14-fold increased risk for developing a solid subsequent malignant neoplasm
American Society of Hematology, Dec. 1-4
The 60th American Society of Hematology Annual Meeting and Exposition The annual meeting of the American Society of Hematology was held from Dec....
ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
Median progression-free survival improved with A+CHP vs CHOP; similar incidence of adverse events
ASH: High Response to Tx After Checkpoint Blockade in NHL, HL
Immunotherapy boosts later therapy for relapsed, refractory non-Hodgkin, Hodgkin lymphoma
FDA Approves First Biosimilar to Non-Hodgkin’s Lymphoma Drug
Truxima approved to treat adults with CD20-positive, B-cell non-Hodgkin's lymphoma
FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma
Adcetris approved in combination with chemo to treat systemic anaplastic large cell lymphoma
Duvelisib Promising for Chronic Lymphocytic Leukemia, SLL
Duvelisib extended progression-free survival to 13.3 months versus 9.9 months for ofatumumab
Rituximab + Lenalidomide Effective in Follicular Lymphoma
Response rate, progression-free survival comparable to those seen with rituximab-chemotherapy
FDA Approves Poteligeo for Rare Types of Non-Hodgkin Lymphoma
Drug approved to treat relapsed or refractory mycosis fungoides and Sézary syndrome
Lymphoma, Leukemia Survivors Have Increased Health Care Use
Survivors who are psychologically distressed use even more services than those who aren't
